Bank Of America Corp Galera Therapeutics, Inc. Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.09 - $0.27 $504 - $1,514	-5,608 Reduced 91.81%	500 $0
Q2 2023 Aug 14, 2023	BUY	$2.5 - $3.42 $10,952 - $14,983	4,381 Added 253.68%	6,108 $19,000
Q1 2023 May 12, 2023	BUY	$1.48 - $2.68 $1,135 - $2,055	767 Added 79.9%	1,727 $4,000
Q4 2022 Feb 10, 2023	BUY	$1.34 - $1.76 $80 - $105	60 Added 6.67%	960 $1,000
Q3 2022 Nov 14, 2022	SELL	$1.15 - $2.1 $2,321 - $4,239	-2,019 Reduced 69.17%	900 $2,000

Q2 2022 Aug 12, 2022	SELL	$1.24 - $2.39 $2,364 - $4,557	-1,907 Reduced 39.52%	2,919 $3,000
Q1 2022 May 16, 2022	SELL	$2.01 - $4.19 $19,533 - $40,718	-9,718 Reduced 66.82%	4,826 $12,000
Q4 2021 Feb 08, 2022	SELL	$1.27 - $8.28 $5,561 - $36,258	-4,379 Reduced 23.14%	14,544 $67,000
Q3 2021 Nov 15, 2021	SELL	$7.04 - $10.49 $43,795 - $65,258	-6,221 Reduced 24.74%	18,923 $154,000
Q2 2021 Sep 13, 2021	BUY	$6.08 - $10.44 $152,875 - $262,503	25,144 New	25,144 $247,000

10.7M

10.3K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $3.76M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.